Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02129361
Other study ID # 2012H0424
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2014
Est. completion date October 31, 2018

Study information

Verified date October 2021
Source Ohio State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is investigating one way to improve health and healthy habits after traumatic brain injury (TBI). The primary goal of this study is to determine if a brief intervention accommodated for persons with moderate or severe TBI is effective in reducing alcohol misuse during the year following injury. It is hypothesized that an adapted Screening, Education and Brief Intervention (adapted SBI) will reduce the number of alcoholic drinks consumed per week over the year following discharge from inpatient rehabilitation, in comparison to a Screening and Education Attention Control condition (SEA control).


Recruitment information / eligibility

Status Completed
Enrollment 139
Est. completion date October 31, 2018
Est. primary completion date October 31, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Sustained a TBI, defined as damage to brain tissue caused by external force and evidenced by loss of consciousness, post-traumatic amnesia, skull fracture, or objective neurological findings - History of alcohol misuse within the year prior to injury - Be at least 18 years old - English-speaking - Have cleared post-traumatic amnesia - Able and willing to provide informed consent Exclusion Criteria: - Language impairments that would preclude participation in interview - Has not cleared post-traumatic amnesia before discharge

Study Design


Intervention

Behavioral:
Adapted Screening and Brief Intervention (Adapted SBI)

Screening & Education Attention Control


Locations

Country Name City State
United States Ohio State University Wexner Medical Center Columbus Ohio

Sponsors (2)

Lead Sponsor Collaborator
Jennifer Bogner, PhD, ABPP U.S. Department of Education

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of alcoholic drinks consumed per week in past month Number of drinks will be recorded at baseline, 6, 9, and 12 months. We will be measuring change in the number of drinks consumed of the course of the year, with the primary outcome being measured at the 12 month assessment. Change from baseline to 12 months post-discharge
Secondary Frequency of alcohol binges in past month Binge is defined as 4 or more drinks in a day for women, 5 or more drinks in a day for men Change in the number of alcohol binges baseline to 12 months post-discharge
Secondary Alcohol expectancies Measured by the shortened Alcohol Expectancies Questionnaire-III 12 months post-discharge
Secondary Number of facts retained about negative consequences of substance misuse Count of number of facts, maximum=8 12 months post-discharge
Secondary Number of alcoholic drinks consumed per week during the past month Count of number of facts, maximum=8 Change from baseline to 3 months post-discharge
Secondary Number of alcoholic drinks consumed per week in the past month Change from baseline to 6 months post-discharge
Secondary Frequency of alcohol binges in past month Binge is defined as 4 or more drinks in a day for women, 5 or more drinks in a day for men Change from baseline to 6 months post-discharge
Secondary Number of alcohol binges in past month Binge is defined as 4 or more drinks in a day for women, 5 or more drinks in a day for men Change from baseline to 3 months post-discharge
Secondary Alcohol expectancies Measured by the shortened Alcohol Expectancies Questionnaire-III 6 months post-discharge
Secondary Alcohol expectancies Measured by the shortened Alcohol Expectancies Questionnaire-III 3 months post-discharge
Secondary Number of facts retained about negative consequences of alcohol use Count of number of facts, maximum=8 3 months post-discharge
Secondary Number of facts retained about negative consequences of alcohol use Count of number of facts, maximum=8 6 months post-discharge
See also
  Status Clinical Trial Phase
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT05503316 - The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System N/A
Completed NCT04356963 - Adjunct VR Pain Management in Acute Brain Injury N/A
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Terminated NCT03698747 - Myelin Imaging in Concussed High School Football Players
Recruiting NCT05130658 - Study to Improve Ambulation in Individuals With TBI Using Virtual Reality -Based Treadmill Training N/A
Recruiting NCT04560946 - Personalized, Augmented Cognitive Training (PACT) for Service Members and Veterans With a History of TBI N/A
Completed NCT05160194 - Gaining Real-Life Skills Over the Web N/A
Recruiting NCT02059941 - Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring Guidelines N/A
Recruiting NCT03940443 - Differences in Mortality and Morbidity in Patients Suffering a Time-critical Condition Between GEMS and HEMS
Recruiting NCT03937947 - Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
Completed NCT04465019 - Exoskeleton Rehabilitation on TBI
Recruiting NCT04530955 - Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS) N/A
Recruiting NCT03899532 - Remote Ischemic Conditioning in Traumatic Brain Injury N/A
Suspended NCT04244058 - Changes in Glutamatergic Neurotransmission of Severe TBI Patients Early Phase 1
Completed NCT03307070 - Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury N/A
Recruiting NCT04274777 - The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
Withdrawn NCT05062148 - Fundamental and Applied Concussion Recovery Modality Research and Development: Applications for the Enhanced Recovery N/A
Withdrawn NCT04199130 - Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI N/A
Withdrawn NCT03626727 - Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia Early Phase 1